# The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil

> **NCT01024660** · EARLY_PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 155 (estimated)

## Conditions studied

- Alzheimer's Disease

## Interventions

- **DRUG:** Donepezil
- **DRUG:** Donepezil
- **DRUG:** Placebo to match Aricept

## Key facts

- **NCT ID:** NCT01024660
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-01
- **Final completion:** 2011-01
- **Target enrollment:** 155 (ESTIMATED)
- **Last updated:** 2011-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01024660

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01024660, "The Effect of Cognitive Function as Measured by Repeated Cognitive Measures After 12 Weeks Treatment With Donepezil". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01024660. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*